Potentiality of immunotherapy against hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Potentiality of immunotherapy against hepatocellular carcinoma

Potentiality of immunotherapy against hepatocellular carcinoma

http://www.wikidata.org/entity/Q26784228

about

The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment.Chimeric antigen receptor-engineered T cells for liver cancers, progress and obstacles.Immune-Mediated Therapies for Liver Cancer.Surface expression of anti-CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A-engineered human umbilical cord mesenchymal stem cells.An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib.A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE.Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.

P2860

Q37336693-06FA1D0A-D270-419B-88FE-69332063E47D Q38873430-EA535390-EA76-4293-983A-83435C49C03A Q39144327-63D3730F-E396-4AB2-873B-B81C3DBAE284 Q40160910-767BF63E-D2B5-4EBE-A216-AF1A7C384458 Q48250035-C78D7A5D-C20E-43E0-8790-10B10AD5B600 Q50063562-E0D03F4B-BA17-4F31-8AB5-4C41914303B5 Q54963955-DCC2E062-1072-4701-9FFD-B4AD680EC8C1

P2860

Potentiality of immunotherapy against hepatocellular carcinoma

http://www.wikidata.org/entity/Q26784228

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Potentiality of immunotherapy against hepatocellular carcinoma

@ast

Potentiality of immunotherapy against hepatocellular carcinoma

@en

Potentiality of immunotherapy against hepatocellular carcinoma

@nl

type

label

Potentiality of immunotherapy against hepatocellular carcinoma

@ast

Potentiality of immunotherapy against hepatocellular carcinoma

@en

Potentiality of immunotherapy against hepatocellular carcinoma

@nl

prefLabel

Potentiality of immunotherapy against hepatocellular carcinoma

@ast

Potentiality of immunotherapy against hepatocellular carcinoma

@en

Potentiality of immunotherapy against hepatocellular carcinoma

@nl

P1433

Q26784228-342165CE-BA13-41C3-80C2-35F0F5340694

P1476

Q26784228-F6ADB9B2-8625-4492-B1AF-A2EF83F6EEC5

P2093

Q26784228-4C02D8D2-BB62-4EC2-A158-76AD75DF06D7

Q26784228-6AF17019-2013-4CA3-8F3C-4E0F5EF2C9D6

Q26784228-A63E26FB-00AF-44B2-AF5D-F28F3ADA7307

Q26784228-CD1B393F-5662-4609-933D-ED149EA036C0

Q26784228-DC7EF43D-1FC1-43F2-90CA-A047638E8325

P2860

Q26784228-04249FA9-D140-48CB-9206-513004CE5EFA

Q26784228-05E76A7C-91DE-4430-A69F-780CE7AE4AC5

Q26784228-088C32A4-B8DA-41ED-BB67-AEB0EBC29E3A

Q26784228-09C09A10-34FF-43DA-B229-6FD7DE6CE438

Q26784228-09E98F1B-3C37-49DD-9119-A6349875AB02

Q26784228-0D9B2B7B-50D6-4DEE-A477-F143D8617520

Q26784228-126C7F1E-4BB0-4C6F-8BD4-80489BEBFBA9

Q26784228-13FE3D27-AE0F-48BA-8186-1EE4C081F6BB

Q26784228-143EA189-EA66-4B55-B0EC-5F9A7EF2352A

Q26784228-1600E270-D104-4E13-8E2F-E34DBCF5E1A2

P304

Q26784228-51065F4D-B18B-4D06-8FD6-A3E86DBA225D

P31

Q26784228-892D251B-DDF3-4000-9947-BAC6C0D254B8

P3181

Q26784228-1D945435-0E29-4604-B903-2F5C770E56F2

P356

Q26784228-10BBF5CC-36DF-42FA-AF87-C526FCBFF680

P407

Q26784228-B453E2CE-42C4-4455-9FE4-557E18A47844

P433

Q26784228-7A0C357F-2754-48FF-A068-2D6BF4DB3FC1

P478

Q26784228-546B6AFF-E595-4CC2-8A33-796AFFD56BF7

P577

Q26784228-B7D53342-8631-4958-99C1-74E959D5B379

P698

Q26784228-C9AA513B-98F9-426F-9C02-5E415EE8C8FE

P921

Q26784228-89051E9B-1606-41E0-823A-EAD75F21CEC1

P932

Q26784228-4072E0E5-E72B-4432-9221-46B2A73530B1

P3181

P356

WJG.V21.I36.10314

P1433

World Journal of Gastroenterology

P1476

Potentiality of immunotherapy against hepatocellular carcinoma

@en

P2093

Itaru Endo

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Tetsuya Nakatsura

http://www.w3.org/2001/XMLSchema#string

Yasushi Uemura

http://www.w3.org/2001/XMLSchema#string

Yu Sawada

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

FOXP3 controls regulatory T cell function through cooperation with NFAT

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Molecular mechanisms of T cell co-stimulation and co-inhibition

Potential of immunotherapy for hepatocellular carcinoma.

Nivolumab plus ipilimumab in advanced melanoma.

Cancer statistics, 2013

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Sorafenib in advanced hepatocellular carcinoma

Reversal of the TCR stop signal by CTLA-4

P304

10314-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2996644

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V21.I36.10314

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26420958

http://www.w3.org/2001/XMLSchema#string

P921

P932

4579878

http://www.w3.org/2001/XMLSchema#string